New research suggests that individuals who come off popular slimming jabs like semaglutide or tirzepatide tend to recover lost weight far faster than those who end conventional lifestyle regimens.
Published data in a major health publication points out that while overweight people frequently drop a large proportion of their total mass while undergoing treatment, the weight comes back at an average rate of 0.8 kg per month upon discontinuation.
"Users using such drugs must be cognizant of the danger of rapid rebound weight gain when the therapy concludes," warns expert Dr. Susan Jebb.
That rate of recovery implies a return to original weight in about one and a half years.
Analyzing Therapies
The research, which looked at dozens of studies involving over 9,000 of participants, contrasted the outcomes of these new drugs with older methods.
Scientists note that individuals who lose weight through diet and exercise generally have a more gradual creep back—approximately 0.1 kg a month—once they finish.
The Reason for the Rapid Regain
Doctors propose the mechanism of the drugs is key to understanding the accelerated regain.
The injections imitate a natural hormone called GLP-1, which moderates feelings of fullness.
"Long-term administration of GLP-1 levels several times higher than normal may cause the system to produce less of its own natural GLP-1, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Stopping of this GLP-1 'fix' leads to hunger is no longer kept in check, making overeating much more probable."
An Ongoing Disease?
Health authorities advise the injections for people with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
Many experts argue that, given the likelihood of weight regain, the treatment might need to be long-term.
This perspective is echoed by drug manufacturers, who note that the results "underscore the chronic character of excess weight," comparing it to managing conditions like diabetes.
User Accounts
Users who have come off the jabs describe a intense return of appetite.
"It felt as if something that goes on and I was suddenly starving," described one woman.
This challenge is worsened if users have not developed permanent lifestyle or habit changes during therapy.
Significant Interest
Survey data indicate that millions of people in the UK have tried these injections in the past year, with demand remaining high.
- Use is greater among women compared to males.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than public health services.
In conclusion, researchers stress that while these medications are powerful tools for shedding pounds, they are not a standalone fix and lasting health benefits hinges on integrated lifestyle support.
